Merops Switch to
Peptidases

Inhibitor

Family Clan Small-molecule
inhibitor SEARCHES BLAST
MEROPS

Other
information

Literature for inhibitor I04.023: plasmin inhibitor

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature Inhibits

(Topics flags: S Structure, A Assay, M Mutation, I Inhibitor, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2022
  1. Alsayejh,B., Kietsiriroje,N., Almutairi,M., Simmons,K., Pechlivani,N., Ponnambalam,S. and Ajjan,R.A.
    Plasmin Inhibitor in Health and Diabetes: Role of the Protein as a Therapeutic Target
    TH Open (2022) 6, e396-e396. PubMed  Europe PubMed DOI  PMC  EPMC  V
  2. Bhagwat,S.R., Choudhary,K., Pandya,N., Sharma,S., Srivastava,S., Kumar,A. and Hajela,K.
    Identification of substrates of MBL Associated Serine Protease-1 (MASP-1) from human plasma using N-terminomics strategy
    Mol Immunol (2022) 151, 114-125. PubMed  Europe PubMed DOI
    3. 2021
  3. Bronic,A., Ferencak,G., Bernat,R., Lenicek-Krleza,J., Dumic,J. and Dabelic,S.
    Association of fibrinogen and plasmin inhibitor, but not coagulation factor XIII gene polymorphisms with coronary artery disease
    J Med Biochem (2021) 40, 138-149. PubMed  Europe PubMed DOI  PMC  EPMC
    4. 2020
  4. Nougier,C., Benoit,R., Simon,M., Desmurs-Clavel,H., Marcotte,G., Argaud,L., David,J.S., Bonnet,A., Negrier,C. and Dargaud,Y.
    Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis
    J Thromb Haemost (2020) PubMed  Europe PubMed DOI  PMC  EPMC
  5. Pedersen,N.B., Stolberg,C.R., Mundbjerg,L.H., Juhl,C.B., Gram,B., Funch-Jensen,P., de Maat,M.P.M., Munster,A.B. and Bladbjerg,E.M.
    Reductions in plasmin inhibitor and fibrinogen predict the improved fibrin clot lysis 6 months after obesity surgery
    Clin Obes (2020) , e12397-e12397. PubMed  Europe PubMed DOI
  6. Singh,S., Saleem,S. and Reed,G.L.
    Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease
    Front Cardiovasc Med (2020) 7, 608899-608899. PubMed  Europe PubMed DOI  PMC  EPMC  V
  7. Verbree-Willemsen,L., Zhang,Y.N., Ibrahim,I., Ooi,S.B.S., Wang,J.W., Mazlan,M.I., Kuan,W.S., Chan,S.P., Peelen,L.M., Grobbee,D.E., Richards,A.M., Lam,C.S.P. and de Kleijn,D.P.V.
    Extracellular vesicle Cystatin C and CD14 are associated with both renal dysfunction and heart failure
    ESC Heart Fail (2020) 7, 2240-2249. PubMed  Europe PubMed DOI
    8. 2019
  8. Teraz-Orosz,A., Csapo,A., Bagoly,Z., Szekely,E.G., Toth,E., Kovacs,B., Bereczky,Z., Muszbek,L. and Katona,E.
    A new ELISA method for the measurement of total alpha2-plasmin inhibitor level in human body fluids
    J Immunol Methods (2019) 471, 27-33. PubMed  Europe PubMed DOI  A
    9. 2018
  9. Vigano,S., D'Andrea,G., Valle,P.D., Santacroce,R., Margaglione,M. and D'Angelo,A.
    A novel allele variant of the SERPINF2 gene responsible for severe plasmin inhibitor (alpha2-antiplasmin) deficiency in an Italian patient
    Thromb Res (2018) 166, 60-62. PubMed  Europe PubMed DOI  M
    10. 2015
  10. Eddy,J.L., Schroeder,J.A., Zimbler,D.L., Bellows,L.E. and Lathem,W.W.
    Impact of the Pla protease substrate alpha2-antiplasmin on the progression of primary pneumonic plague
    Infect Immun (2015) 83, 4837-4847. PubMed  Europe PubMed DOI
    11. 2011
  11. Lu,B.G., Sofian,T., Law,R.H., Coughlin,P.B. and Horvath,A.J.
    Contribution of conserved lysine residues in the alpha2-antiplasmin C terminus to plasmin binding and inhibition
    J Biol Chem (2011) 286, 24544-24552. PubMed  Europe PubMed DOI
  12. Uitte de Willige,S., Miedzak,M., Carter,A.M., Lisman,T., Rosendaal,F.R., Grant,P.J., Philippou,H. and Ariens,R.A.
    Proteolytic and genetic variation of the alpha-2-antiplasmin C-terminus in myocardial infarction
    Blood (2011) 117, 6694-6701. PubMed  Europe PubMed DOI
    13. 2008
  13. Carpenter,S.L. and Mathew,P.
    Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance
    Haemophilia (2008) 14, 1250-1254. PubMed  Europe PubMed DOI  V
  14. Law,R.H., Sofian,T., Kan,W.T., Horvath,A.J., Hitchen,C.R., Langendorf,C.G., Buckle,A.M., Whisstock,J.C. and Coughlin,P.B.
    X-ray crystal structure of the fibrinolysis inhibitor alpha2-antiplasmin
    Blood (2008) 111, 2049-2052. PubMed  Europe PubMed DOI  S
  15. Maino,A., Garagiola,I., Artoni,A., Al-Humood,S. and Peyvandi,F.
    A novel mutation of alpha2-plasmin inhibitor gene causes an inherited deficiency and a bleeding tendency
    Haemophilia (2008) 14, 166-166. PubMed  Europe PubMed DOI  M
    16. 2007
  16. Sazonova,I.Y., Thomas,B.M., Gladysheva,I.P., Houng,A.K. and Reed,G.L.
    Fibrinolysis is amplified by converting alpha-antiplasmin from a plasmin inhibitor to a substrate
    J Thromb Haemost (2007) 5, 2087-2094. PubMed  Europe PubMed DOI
    17. 2006
  17. Gallimore,M.J.
    More on: Discovery of alpha2-plasmin inhibitor and its congenital deficiency
    J Thromb Haemost (2006) 4, 284-285. PubMed  Europe PubMed DOI
    18. 2005
  18. Aoki,N.
    Discovery of alpha2-plasmin inhibitor and its congenital deficiency
    J Thromb Haemost (2005) 3, 623-631. PubMed  Europe PubMed DOI
  19. Aoki,N.
    The past, present and future of plasmin inhibitor
    Thromb Res (2005) 116, 455-464. PubMed  Europe PubMed DOI  V
  20. Coughlin,P.B.
    Antiplasmin: the forgotten serpin?
    FEBS J (2005) 272, 4852-4857. PubMed  Europe PubMed DOI  V
    21. 2003
  21. [YEAR:4-2-2003]Frank,P.S., Douglas,J.T., Locher,M., Llinas,M. and Schaller,J.
    Structural/functional characterization of the alpha2-plasmin inhibitor C-terminal peptide
    Biochemistry (4-2-2003) 42, 1078-1085. PubMed  Europe PubMed DOI
    22. 2002
  22. [YEAR:5-3-2002]Hsieh,M.C. and Cooperman,B.S.
    Inhibition of prostate-specific antigen (PSA) by alpha(1)-antichymotrypsin: salt-dependent activation mediated by a conformational change
    Biochemistry (5-3-2002) 41, 2990-2997. PubMed  Europe PubMed DOI
    23. 2001
  23. [YEAR:11-6-2001]Lijnen,H.R., Van Hoef,B. and Collen,D.
    Inactivation of the serpin alpha(2)-antiplasmin by stromelysin-1
    Biochim Biophys Acta (11-6-2001) 1547, 206-213. PubMed  Europe PubMed DOI
    24. 1998
  24. Und,B. and Thorsen,S.
    A new mutation (Val384Met) in the human plasmin inhibitor gene associated with plasmin inhibitor deficiency and bleeding tendency
    Fibrinolysis Proteolysis (1998) 12 Suppl. 1, 20-20.  M
    25. 1993
  25. Bangert,K., Johnsen,A.H., Christensen,U. and Thorsen,S.
    Different N-terminal forms of alpha2-plasmin inhibitor in human plasma
    Biochem J (1993) 291, 623-625. PubMed  Europe PubMed  PMC  EPMC
    26. 1992
  26. Christensen,S. and Sottrup-Jensen,L.
    Bovine alpha2-antiplasmin. N-terminal and reactive site sequence
    FEBS Lett (1992) 312, 100-104. PubMed  Europe PubMed DOI
    27. 1989
  27. Shieh,B.H., Potempa,J. and Travis,J.
    The use of alpha2-antiplasmin as a model for the demonstration of complex reversibility in serpins
    J Biol Chem (1989) 264, 13420-13423. PubMed  Europe PubMed
    28. 1988
  28. [YEAR:15-9-1988]Hortin,G.L., Gibson,B.L. and Fok,K.F.
    Alpha 2-antiplasmin's carboxy-terminal lysine residue is a major site of interaction with plasmin
    Biochem Biophys Res Commun (15-9-1988) 155, 591-596. PubMed  Europe PubMed
  29. [YEAR:5-8-1988]Potempa,J., Shieh,B.H. and Travis,J.
    Alpha-2-antiplasmin: a serpin with two separate but overlapping reactive sites
    Science (5-8-1988) 241, 699-700. PubMed  Europe PubMed
  30. [YEAR:4-1-1988]Sugiyama,N., Sasaki,T., Iwamoto,M. and Abiko,Y.
    Binding site of alpha 2-plasmin inhibitor to plasminogen
    Biochim Biophys Acta (4-1-1988) 952, 1-7. PubMed  Europe PubMed  I
    31. 1987
  31. Shieh,B.H. and Travis,J.
    The reactive site of human alpha 2-antiplasmin
    J Biol Chem (1987) 262, 6055-6059. PubMed  Europe PubMed
    32. 1986
  32. Lijnen,H.R. and Collen,D.
    alpha2-Antiplasmin
    [ISSN:0-444-80763-2] (1986) , 457-476.
    33. 1984
  33. [YEAR:1-9-1984]Hogstorp,H., Jacobsson,H., Wallin,R. and Saldeen,T.
    Two forms of alpha 2-antiplasmin: differences in KAV and isoelectric point
    Thromb Res (1-9-1984) 35, 559-565. PubMed  Europe PubMed
  34. [YEAR:15-2-1984]Kluft,C., Los,P. and Jie,A.F.
    The molecular form of alpha 2-antiplasmin with affinity for plasminogen is selectively bound to fibrin by factor XIII
    Thromb Res (15-2-1984) 33, 419-425. PubMed  Europe PubMed
    35. 1983
  35. [YEAR:15-7-1983]Gogstad,G.O., Stormorken,H. and Solum,N.O.
    Platelet alpha 2-antiplasmin is located in the platelet alpha-granules
    Thromb Res (15-7-1983) 31, 387-390. PubMed  Europe PubMed
  36. [YEAR:21-3-1983]Ichinose,A., Tamaki,T. and Aoki,N.
    Factor XIII-mediated cross-linking of NH2-terminal peptide of alpha 2-plasmin inhibitor to fibrin
    FEBS Lett (21-3-1983) 153, 369-371. PubMed  Europe PubMed DOI
    37. 1982
  37. Kluft,C., Vellenga,E., Brommer,E.J. and Wijngaards,G.
    A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha 2-antiplasmin
    Blood (1982) 59, 1169-1180. PubMed  Europe PubMed  M  I
  38. Lijnen,H.R., Wiman,B., Van Hoef,B. and Collen,D.
    Purification and partial primary structure of cyanogen bromide fragments from human alpha2-antiplasmin
    Thromb Res (1982) 27, 83-89. PubMed  Europe PubMed
  39. Lijnen,H.R., Wiman,B. and Collen,D.
    Partial primary structure of human alpha2-antiplasmin - homology with other plasma protease inhibitors
    Thromb Haemost (1982) 48, 311-314. PubMed  Europe PubMed
  40. Miles,L.A., Plow,E.F., Donnelly,K.J., Hougie,C. and Griffin,J.H.
    A bleeding disorder due to deficiency of alpha 2-antiplasmin
    Blood (1982) 59, 1246-1251. PubMed  Europe PubMed
  41. [YEAR:26-7-1982]Nilsson,T., Sjoholm,I. and Wiman,B.
    Circular dichroism studies on alpha 2-antiplasmin and its interactions with plasmin and plasminogen
    Biochim Biophys Acta (26-7-1982) 705, 264-270. PubMed  Europe PubMed
  42. [YEAR:1-6-1982]Nilsson,T. and Wiman,B.
    On the structure of the stable complex between plasmin and alpha-2-antiplasmin
    FEBS Lett (1-6-1982) 142, 111-114. PubMed  Europe PubMed DOI
  43. [YEAR:25-12-1982]Tamaki,T. and Aoki,N.
    Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor
    J Biol Chem (25-12-1982) 257, 14767-14772. PubMed  Europe PubMed
  44. Teger-Nilsson,A.-C., Friberger,P. and Gyzander,E.
    Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate
    Scand J Clin Lab Invest (1982) 42, 403-409. DOI  A
  45. [YEAR:15-10-1982]Wiman,B., Nilsson,T. and Cedergren,B.
    Studies on a form of alpha 2-antiplasmin in plasma which does not interact with the lysine-binding sites in plasminogen
    Thromb Res (15-10-1982) 28, 193-199. PubMed  Europe PubMed
  46. Yoshioka,A., Kamitsuji,H., Takase,T., Iida,Y., Tsukada,S., Mikami,S. and Fukui,H.
    Congenital deficiency of alpha 2-plasmin inhibitor in three sisters
    Haemostasis (1982) 11, 176-184. PubMed  Europe PubMed  M  I
    47. 1981
  47. Clemmensen,I., Thorsen,S., Mullertz,S. and Petersen,L.C.
    Properties of three different molecular forms of the alpha 2 plasmin inhibitor
    Eur J Biochem (1981) 120, 105-112. PubMed  Europe PubMed
  48. [YEAR:1-1-1981]Kluft,C. and Los,N.
    Demonstration of two forms of alpha 2-antiplasmin in plasma by modified crossed immunoelectrophoresis
    Thromb Res (1-1-1981) 21, 65-71. PubMed  Europe PubMed
  49. Korninger,C. and Collen,D.
    Neutralization of human extrinsic (tissue-type) plasminogen activator in human plasma: no evidence for a specific inhibitor
    Thromb Haemost (1981) 46, 662-665. PubMed  Europe PubMed
  50. Plow,E.F. and Collen,D.
    The presence and release of alpha 2-antiplasmin from human platelets
    Blood (1981) 58, 1069-1074. PubMed  Europe PubMed
  51. Wiman,B.
    [32] Human alpha-2-antiplasmin
    Methods Enzymol (1981) 80, 395-408. DOI  V
    52. 1980
  52. Aoki,N., Sakata,Y., Matsuda,M. and Tateno,K.
    Fibrinolytic states in a patient with congenital deficiency of alpha 2-plasmin inhibitor
    Blood (1980) 55, 483-488. PubMed  Europe PubMed  M
  53. [YEAR:1-2-1980]Matsuda,M., Wakabayashi,K., Aoki,N. and Morioka,Y.
    Alpha 2-Plasmin inhibitor is among acute phase reactants
    Thromb Res (1-2-1980) 17, 527-532. PubMed  Europe PubMed
  54. [YEAR:10-4-1980]Plow,E.F., Wiman,B. and Collen,D.
    Changes in antigenic structure and conformation of alpha 2-antiplasmin induced by interaction with plasmin
    J Biol Chem (10-4-1980) 255, 2902-2906. PubMed  Europe PubMed
  55. [YEAR:1-4-1980]Sandbjerg Hansen,M. and Clemmensen,I.
    Partial purification and characterization of a new fast-acting plasmin inhibitor from human platelets. Evidence for non-identity with the known plasma proteinase inhibitors
    Biochem J (1-4-1980) 187, 173-180. PubMed  Europe PubMed  PMC  EPMC
  56. [YEAR:1-10-1980]Wiman,B.
    Affinity-chromatographic purification of human alpha 2-antiplasmin
    Biochem J (1-10-1980) 191, 229-232. PubMed  Europe PubMed  PMC  EPMC
    57. 1979
  57. Aoki,N.
    Natural inhibitors of fibrinolysis
    Prog Cardiovasc Dis (1979) 21, 267-286. PubMed  Europe PubMed
  58. Aoki,N., Saito,H., Kamiya,T., Koie,K., Sakata,Y. and Kobakura,M.
    Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency
    J Clin Invest (1979) 63, 877-884. PubMed  Europe PubMed  PMC  EPMC  M
  59. [YEAR:12-5-1979]Collen,D.
    alpha2-Antiplasmin inhibitor deficiency
    Lancet (12-5-1979) 1, 1039-1040. PubMed  Europe PubMed  M
  60. Collen,D. and Wiman,B.
    Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasma
    Blood (1979) 53, 313-324. PubMed  Europe PubMed
  61. Collen,D. and Verstraete,M.
    alpha 2-Antiplasmin consumption and fibrinogen breakdown during thrombolytic therapy
    Thromb Res (1979) 14, 631-639. PubMed  Europe PubMed
  62. Gallimore,M.J., Amundsen,E., Aasen,A.O., Larsbraaten,M., Lyngaas,K. and Svendsen,L.
    Studies on plasma antiplasmin activity using a new plasmin specific chromogenic tripeptide substrate
    Thromb Res (1979) 14, 51-60. PubMed  Europe PubMed
  63. [YEAR:28-7-1979]Kluft,C., Vellenga,E. and Brommer,E.J.
    Homozygous alpha 2-antiplasmin deficiency
    Lancet (28-7-1979) 2, 206-206. PubMed  Europe PubMed  M
  64. Saito,H., Goldsmith,G.H., Moroi,M. and Aoki,N.
    Inhibitory spectrum of alpha2-plasmin inhibitor
    Proc Natl Acad Sci U S A (1979) 76, 2013-2017. PubMed  Europe PubMed  PMC  EPMC
  65. [YEAR:25-7-1979]Wiman,B., Lijnen,H.R. and Collen,D.
    On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen
    Biochim Biophys Acta (25-7-1979) 579, 142-154. PubMed  Europe PubMed
  66. [YEAR:25-9-1979]Wiman,B. and Collen,D.
    On the mechanism of the reaction between human alpha 2-antiplasmin and plasmin
    J Biol Chem (25-9-1979) 254, 9291-9297. PubMed  Europe PubMed
    67. 1978
  67. [YEAR:28-2-1978]Aoki,N., Moroi,M. and Tachiya,K.
    Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin
    Thromb Haemost (28-2-1978) 39, 22-31. PubMed  Europe PubMed
  68. [YEAR:1-11-1978]Christensen,U. and Clemmensen,I.
    Purification and reaction mechanisms of the primary inhibitor of plasmin from human plasma
    Biochem J (1-11-1978) 175, 635-641. PubMed  Europe PubMed  PMC  EPMC
  69. Collen,D. and Wiman,B.
    Fast-acting plasmin inhibitor in human plasma
    Blood (1978) 51, 563-569. PubMed  Europe PubMed
  70. [YEAR:23-12-1978]Koie,K., Kamiya,T., Ogata,K. and Takamatsu,J.
    Alpha2-plasmin-inhibitor deficiency (Miyasato disease)
    Lancet (23-12-1978) 2, 1334-1336. PubMed  Europe PubMed  M
  71. Naito,K. and Aoki,N.
    Assay of alpha2-plasmin inhibitor activity by means of a plasmin specific tripeptide substrate
    Thromb Res (1978) 12, 1147-1156. PubMed  Europe PubMed
  72. [YEAR:1-6-1978]Wiman,B., Boman,L. and Collen,D.
    On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin
    Eur J Biochem (1-6-1978) 87, 143-146. PubMed  Europe PubMed
  73. [YEAR:15-3-1978]Wiman,B. and Collen,D.
    On the kinetics of the reaction between human antiplasmin and plasmin
    Eur J Biochem (15-3-1978) 84, 573-578. PubMed  Europe PubMed
    74. 1977
  74. Aoki,N., Moroi,M., Matsuda,M. and Tachiya,K.
    The behavior of alpha2-plasmin inhibitor in fibrinolytic states
    J Clin Invest (1977) 60, 361-369. PubMed  Europe PubMed DOI  PMC  EPMC
  75. [YEAR:1-5-1977]Christensen,U. and Clemmensen,I.
    Kinetic properties of the primary inhibitor of plasmin from human plasma
    Biochem J (1-5-1977) 163, 389-391. PubMed  Europe PubMed  PMC  EPMC
  76. [YEAR:13-10-1977]Edy,J. and Collen,D.
    The interaction in human plasma of antiplasmin, the fast-reacting plasmin inhibitor, with plasmin, thrombin, trypsin and chymotrypsin
    Biochim Biophys Acta (13-10-1977) 484, 423-432. PubMed  Europe PubMed
  77. Moroi,M. and Aoki,N.
    On the interaction of alpha2-plasmin inhibitor and proteases. Evidence for the formation of a covalent crosslinkage and non-covalent weak bondings between the inhibitor and proteases
    Biochim Biophys Acta (1977) 482, 412-420. PubMed  Europe PubMed
  78. Moroi,M. and Aoki,N.
    Inhibition of plasminogen binding to fibrin by alpha2-plasmin inhibitor
    Thromb Res (1977) 10, 851-856. PubMed  Europe PubMed
    79. 1976
  79. Bagge,L., Bjork,I., Saldeen,T. and Wallin,R.
    Purification and characterization of an inhibitor of plasminogen activation from post-traumatic patients
    Forensic Sci (1976) 7, 83-86.
  80. [YEAR:1-10-1976]Collen,D.
    Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma
    Eur J Biochem (1-10-1976) 69, 209-216. PubMed  Europe PubMed
  81. [YEAR:10-10-1976]Moroi,M. and Aoki,N.
    Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis
    J Biol Chem (10-10-1976) 251, 5956-5965. PubMed  Europe PubMed
  82. [YEAR:1-12-1976]Mullertz,S. and Clemmensen,I.
    The primary inhibitor of plasmin in human plasma
    Biochem J (1-12-1976) 159, 545-553. PubMed  Europe PubMed  PMC  EPMC
    83. 1972
  83. Ganguly,P.
    A low molecular weight antiplasmin of human blood platelets
    Clin Chim Acta (1972) 39, 466-468. PubMed  Europe PubMed
    84. 1970
  84. [YEAR:31-10-1970]Wakabayashi,K., Fujikawa,K. and Abe,T.
    Some properties of an antiplasmin substance from rabbit platelets
    Thromb Diath Haemorrh (31-10-1970) 24, 76-84. PubMed  Europe PubMed
    85. 1966
  85. [YEAR:10-11-1966]Rimon,A., Shamash,Y. and Shapiro,B.
    The plasmin inhibitor of human plasma. IV. Its action on plasmin, trypsin, chymotrypsin, and thrombin
    J Biol Chem (10-11-1966) 241, 5102-5107. PubMed  Europe PubMed
    86. 1958
  86. [YEAR:1-11-1958]Norman,P.S. and Hill,B.M.
    Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma
    J Exp Med (1-11-1958) 108, 639-649. PubMed  Europe PubMed  PMC  EPMC
  87. [YEAR:1-7-1958]Norman,P.S.
    Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma
    J Exp Med (1-7-1958) 108, 53-68. PubMed  Europe PubMed  PMC  EPMC

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2026 EBI
Terms of use